Sudan News Gazette

Updates from Sudan!

Healthcare

Healthcare

DoH welcomes over 500 applicants in the 2024 Medical Education Programmes

ABU DHABI: A total of 505 applicants have been accepted out of 1,711 applications across the Medical Education Programmes offered by the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, representing a 10 % i…

Healthcare

DoH welcomes over 500 applicants in the 2024 Medical Education Programmes

ABU DHABI: A total of 505 applicants have been accepted out of 1,711 applications across the Medical Education Programmes offered by the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, representing a 10 % i…

Healthcare

Emirates Health Services signs partnership agreement with Texas Children’s Hospital

DUBAI: The Emirates Health Services (EHS) today signed an agreement with Texas Children’s Hospital in the United States of America to improve children’s health care services and strengthen medical cooperation between the two parties through the Visiti…

Healthcare

Brain-imaging study reveals curiosity as it emerges

WASHINGTON: A research team based at Columbia’s Zuckerman Institute has for the first time witnessed what is happening in the human brain when feelings of curiosity like this arise.

In a study published in the Journal of Neuroscience, the scientists …

Healthcare

Burjeel Holdings receives NIHS Institutional Accreditation

ABU DHABI: Burjeel Holdings has achieved a significant milestone by receiving institutional accreditation from the National Institute for Health Specialties (NIHS), a prestigious accreditation programme in the UAE. Burjeel Holdings is the first privat…

Healthcare

COVID-19 still kills 1,700 a week: WHO

GENEVA: COVID-19 is still killing around 1,700 people a week around the world, the World Health Organisation (WHO) said Thursday, urging those most at risk to continue receiving vaccinations against the virus.

At a press conference, WHO Director-Gene…

Healthcare

IROS, Prilenia and International Huntington’s Disease Association collaborate on first-ever Huntington’s disease trial in region

DUBAI: IROS, an Abu Dhabi-based contract research organisation (part of the M42 group), has partnered with Prilenia Therapeutics, a clinical-stage biotech company, and the International Huntington’s Disease Association (IHA) to plan the first-ever cli…